Business Wire

Vista Entertainment Solutions Signs Les Cinémas Pathé Gaumont, Leaders of Exhibition Theatre in France

Del

Vista Entertainment Solutions Ltd (“Vista Cinema”), a Vista Group company (NZX & ASX: VGL), has signed an agreement with Les Cinémas Pathé Gaumont, leaders of exhibition theatre in France, who also operate in the Netherlands, Switzerland and Belgium.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180611006332/en/

At the end of 2017, Les Cinémas Pathé Gaumont operated 69 cinemas in France with a total of 773 screens. It saw 46.2 million admissions in 2017. Building on the experience of using Vista Cinema in Switzerland and Belgium, Les Cinémas Pathé Gaumont will engage the Vista Cinema management software suite for the sale of tickets and concessions across the French circuit.

Overall, Les Cinémas Pathé Gaumont has opted to utilise the breadth and depth of the Vista Cinema product portfolio; included is Vista Cinema’s Food & Beverage functionality to operate their Starbucks coffee venues and other specialised Food & Beverage offerings, and the innovative offerings of Digital Signage, Vista App “InTouch,” Film Programming and Analytics, among other applications.

The roll-out of the Vista Cinema software suite across Les Cinémas Pathé Gaumont in France is scheduled for 2019.

For their projects in Northern Africa, Les Cinémas Pathé Gaumont has chosen the cloud-based cinema management system Veezi, another innovative solution developed by Vista Cinema. Veezi is already operating successfully on the African continent and meets local payment and reporting requirements.

Mischa Kay, Managing Director of Vista Entertainment Solutions, EMEA, states: “In what can only be described as a monumental turning point for Vista Cinema in France, we are incredibly proud to count Les Cinémas Pathé Gaumont amongst our customers. Les Cinémas Pathé Gaumont’s drive for innovation has led to this partnership and we are excited to see how our products will contribute even more to Les Cinémas Pathé Gaumont’s efforts of pushing the boundaries of customer service and operational efficiency.”

Martine Odillard, Chairman of Les Cinémas Pathé Gaumont, says: “We are very confident in our choice to implement the Vista Cinema software solution. This milestone is key to go further in our strategy of upgrading and modernizing our cinemas.”

Till Cussmann, SVP Sales EMEA & General Manager for Europe, also describes the agreement with Les Cinémas Pathé Gaumont as a major turning point for Vista Cinema in Europe: “With one of the most innovative and well-respected pan-European cinema chains moving to Vista products, Vista has proven once again that they are capable of managing the complexities of the European local markets. Our products are creating real added value to the digital transformation process of cinemas and in doing so, also to moviegoers.”

About Les Cinémas Pathé Gaumont

Les Cinémas Pathé Gaumont are leaders of exhibition theatres in France, the Netherlands and Switzerland. They are also present in Belgium. At the end of 2017, Les Cinémas Gaumont Pathé operated 111 movie theatres, totaling 1,091 screens, 66,2 million admissions and 760 million euros in revenue. Les Cinémas Pathé Gaumont’s strategy of upgrading and modernising is based on an active policy of creation, reconstruction, and renovation, constant innovation with the latest technologies, new and adapted services and an optimised viewer experience, at the cinema and online.

Les Cinémas Pathé Gaumont is owned by Pathé, one of the biggest film producers in Europe and a major player in film distribution.

About Vista Entertainment Solutions:

Vista Entertainment Solutions Ltd (“Vista Cinema”) is the world leader in cinema management software solutions, with installations in more than 90 countries around the world and an estimated 38% global market share in the Large Cinema Circuit market. The Vista Cinema software product line comprises multiple modules, integrated and scalable, suited to cinema exhibitors operating 20+ screens and 100s of cinemas. Vista Cinema is headquartered in Auckland, New Zealand.

Website: www.vista.co
Twitter: @VistaCinema
LinkedIn: www.linkedin.com/company/vista-entertainment-solutions

Contact information

Media Contacts:
For Les Cinémas Pathé Gaumont
Emilie Imbert
Tél. 09 54 26 31 17
Port. 06 71 88 27 65
relationspresse@eimbert.com
or
For Vista Group International/NZ
Christine Fenby
+64 21 727 006
christine.fenby@vista.co
or
For Vista Entertainment Solutions/EMEA
Sharon Heideman
+44 7720 591 196
sharon.heideman@vista.co
or
For Vista Group International/USA
MBC
Maggie Begley
+1 310 390 0101
maggie@mbcprinc.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors17.6.2019 16:00:00 CESTPressemelding

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα, being studied in patients with advanced solid tumors. The Phase 1 study is a dose finding study of BI 765063, a myeloid checkpoint inhibitor, administered as a single agent and in combination with Boehringer Ingelheim’s monoclonal antibody PD-1 antagonist BI 754091, a T-lymphocyte checkpoint inhibitor. “We are very pleased with the progress achieved on BI 765063’s program and having the first patient dosed marks a significant milestone in the product’s development. The advancement of a myeloid cell checkpoint blocking monoclonal antibody into the clinic exemplifies Boehringer Ingelheim’s commitment to the next wave of innovation in cancer immunology therapies, with the goal of meaningfully improving outcomes fo

MagicStay Raises €3 Million to Accelerate Its International Development17.6.2019 15:58:00 CESTPressemelding

The apartment rental platform dedicated to business travelers, MagicStay.com , announces its full integration into the main business travel booking tools and a €3 million A-series to pursue its development, bringing the amounts raised to more than €8 million since its launch in 2013. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005644/en/ William Lecerf and Valéry Linyer, co-founders of MagicStay (Photo: MagicStay) "This fundraising will allow us to recruit talent to accelerate our growth. We want to sign a quarter of the major French companies and approach one million homes before the end of the year, thanks to the exclusive technologies we now have at our disposal", says Valéry Linÿer, CEO and co-founder, who adds: "We have four main advantages over our competitors: we meet the challenges of duty of care, we are able to customize our tool to meet the constraints of each large company for short and long stays, we ha

EURid Shows a 94% Reduction of Its Footprint since 201217.6.2019 15:32:00 CESTPressemelding

EURid, the not-for-profit organisation that operates the .eu and .ею top-level domains, is the first European TLD registry that registered for the EU Eco-Management and Audit Scheme (EMAS) from 2011. Since then, EURid has regularly assessed the environmental impact of its activities and monitored the compliance of its policies and procedures. As over the past four years, in Q2 2019 EURid was audited for the CO2 emissions of the previous year, resulting in an overall footprint of 135 tons CO2eq, which shows a 94% reduction since 2012. “We have achieved carbon neutrality via several actions and the compensation of the audited emissions. We were and are still among the first in our sector to report on our commitment to protect the environment”, commented CEO Marc Van Wesemael. Through EMAS, EURid has had the opportunity to support a multitude of global sustainability initiatives, like the Ugandan Borehole Project, Ecomapuà Project in the Amazon, the Dak Rung Hydropower Project in Vietnam,

Animation, Sound & Vibration – How Visa is Reinforcing Consumer Trust in a Changing Payments World17.6.2019 15:00:00 CESTPressemelding

Visa (NYSE: V) today announced global adoption of its sensory branding suite in 25 countries via more than a dozen new partnerships. The suite is comprised of sound, animation and haptic brand cues that occur with a Visa payment transaction. In a digital world increasingly filled with voice-commands, networked appliances and unattended retail environments, Visa’s sensory branding cues offer new ways to enhance the customer experience and convey the trust and security that the Visa brand represents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005240/en/ Visa was the first major payment brand to introduce multi-sensory branding, which included animation, sound and haptic vibration expressions of its brand. After an extensive creation and selection process that involved focus groups and elimination rounds, Visa landed on a single ‘energetic’ and ‘optimistic’ sound, and complementary animation and haptic vibration. Sinc

Study from Project Management Institute Identifies Six AI Technologies Impacting Project Professionals17.6.2019 14:40:00 CESTPressemelding

Project Management Institute (PMI) today released its 2019 Pulse of the Profession® In-Depth Report: AI Innovators: Cracking the Code on Project Performance. The report provides an in-depth look at how artificial intelligence (AI) is impacting organizations and the project management profession. Findings reveal that AI disruption is happening and at a large scale: 81 percent of respondents report their organization is being impacted by AI technologies; 37 percent say adopting AI technologies is a high priority for their organization; and project professionals say they expect the proportion of the projects they manage using AI will jump from 23 to 37 percent over the next three years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005558/en/ These insights from a survey of 551 project management practitioners globally show that the presence of AI technologies will continue to grow, requiring shifts in how projects are m

RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration17.6.2019 13:15:00 CESTPressemelding

RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced positive top-line results from its SUSHI study, Phase 1/2a single ascending dose clinical study of RBM-007, anti-FGF2 aptamer, in nine subjects with wet Age-Related Macular Degeneration (wet AMD). SUSHI study achieved the primary endpoint of safety and tolerability, and also demonstrated efficacy trends in favor of RBM-007. Subjects recruited for the SUSHI Study had wet AMD that was poorly responsive to previous intravitreal anti-VEGF therapy. Through the 56-Day exit visit, excluding one uncompleted case in the last cohort, single dose of RBM-007 demonstrated no dose-limiting toxicities, no systemic or ocular serious adverse events. One subject in Cohort 3 showed anterior inflammation, which was resolved after one day of topical prednisolone treatment. Rescue treatment with anti-VEGF therapy was ava